This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Kagoshima University. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Salunya Tancharoen: Innovator in Periodontal Disease Treatment
Introduction
Salunya Tancharoen is a notable inventor based in Bangkok, Thailand. He has made significant contributions to the field of dental health, particularly in the treatment and diagnosis of periodontal disease. His innovative approach has the potential to improve the quality of life for many individuals suffering from this condition.
Latest Patents
Tancharoen holds a patent for a groundbreaking invention titled "Periodontal-disease-specific peptide, and treatment and diagnosis of periodontal disease using same." This invention provides an inhibitor of an autoimmune response to a periodontal bacterial enzymatic degradation product of keratin in the gingival epithelium of mammals. The patent outlines a method for diagnosing periodontal disease, which includes detecting keratin or its degradation products and autoantibodies. This innovative approach aims to enhance the prophylaxis and treatment of periodontal disease and its complications.
Career Highlights
Throughout his career, Salunya Tancharoen has worked with esteemed institutions, including Kagoshima University and JNC Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas in dental health.
Collaborations
Tancharoen has collaborated with notable colleagues such as Ko-ichi Kawahara and Lyang-ja Lee. These partnerships have contributed to the advancement of his research and the successful development of his patent.
Conclusion
Salunya Tancharoen's work in the field of periodontal disease treatment showcases his dedication to improving dental health through innovation. His patent represents a significant step forward in the diagnosis and treatment of this common condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile